Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2020 vs. 2019.

SAN FRANCISCO – Pacing the stage at this year's China Showcase Saturday, Chinabio CEO Greg Scott sounded a touch disappointed. Last year lacked the kind of record-breaking stats he likes to punctuate with iconic explosions, a common image in his widely valued China health care talks. "Simply stated, business is continuing as normal," he said.

A quick look back at top stories.

The top 10 biopharma stock gainers and losers for the week.

Total raised in public, private and other financings of biopharma companies, comparing 2020 vs. 2019.

Year-to-date money raised in public, private and other financings of biopharma companies.

Therapeutic area data reported by biopharma companies on phase II trials in December 2019.